Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
We have maintained a Neutral rating on Masco Corporation (MAS - Analyst Report) following appraisal of fourth quarter and fiscal year 2011 results.
The company reported a broader loss of 9 cents per share in the fourth quarter of 2011 compared with a loss of 8 cents per share in the fourth quarter of 2010 (excluding special items) and the Zacks Consensus Estimate of a loss of 3 cents. Marginal top-line growth and reduced gross margins led to escalating loss. Sales in the quarter were flat at $1.7 billion compared with the fourth quarter of 2010 due to low cabinet, plumbing and windows and door sales. Gross margins were 21.9% compared with 23.5% in the year-ago quarter. (Please read our full report at Masco Reports Broader Loss).
Masco Corporation manufactures, sells, and installs home improvement and building products. Its mains products and services include plumbing products, cabinets and related products, installation and other services, decorative architectural products, and other specialty products. The company owns some of the popular brands like KraftMaid and Merillat cabinets, Delta and Hansgrohe faucets, Behr paint and Milgard windows. Moreover, the company is also experimenting on new products. We believe that the company’s leadership brands, its continued focus on innovation and new product launches can help drive growth in the long term.
However, falling prices have made homes a less lucrative investment for buyers, reducing demand for Masco’s products. Masco’s business largely depends on the home improvement and new home construction market which is currently experiencing a slowdown. The downturn in the housing industry led to lower demand for new homes and an oversupply of homes in the market, thus generating a downward pressure on home prices. This combined with low consumer confidence, high unemployment rates and reduced credit availability lowered discretionary consumer spending for home improvements and new home construction, thus hurting the company’s earnings and sales. Further, new homes are facing tough competition from housing alternatives, including resale homes, foreclosed homes, short sale homes and rental housing. Besides, the Euro-zone crisis has capped overall economic activity with spill-over effects felt in the US too, limiting top-line growth at Masco. Other than that rising prices of raw materials are impacting the company’s margins.
In 2011, the company completed the restructuring and rationalizing of its businesses and managing its cost structure in order to cope with challenging industry conditions. The company’s initiatives include business consolidations, system implementations, plant closures, improvement in the global supply chain and headcount reductions. The main rationale behind this move is efficient cost management. The restructuring initiatives are expected to result in about $150 million of gross cost reduction before inflation in 2012.
Management however believes that its cost cutting initiatives and top-line growth efforts, though failing to fetch the desired results in 2011, will drive significant improvement in 2012, even if the housing market continues to remain weak. Management believes the segments that were most hurt by restructuring, namely Installation and North American Cabinet Operations, would begin to show signs of growth in 2012. Sharing management’s optimism we prefer to wait and see how the year 2012 unfolds for homebuilders.
Get the full Analyst Report on MAS - FREE